Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.40
Bid: 22.00
Ask: 24.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.091%)
Open: 24.00
High: 24.40
Low: 24.00
Prev. Close: 23.00
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oncimmune Starts Trading On AIM As Motorpoint Shares Stay Firm (ALLIPO)

Wed, 18th May 2016 08:46

LONDON (Alliance News) - Oncimmune Holdings PLC shares slipped on their debut on London's AIM market on Wednesday, as unconditional dealings also started in Motorpoint Group PLC shares.

Oncimmune, an early cancer detection technology company, raised GBP11.0 million through the issue of shares at 130.00 pence per share. Its market capitalisation upon admission was around GBP66.3 million.

Shares in the company edged down in early dealings though, to 129.00p.

Oncimmune intends to use proceeds from the float to continue to develop its products, focused on auto-antibody tests which it said have the potential to detect cancer up to four years earlier than other methods, and can be applied to a "very wide range" of solid tumour types.

Meanwhile, unconditional dealings started on the London Main Market in shares of car dealer Motorpoint Group PLC. It floated last week, raising GBP100.0 million and starting life as a listed company with a GBP200.0 million market capitalisation.

Motorpoint shares were trading at 225.00p on Wednesday, 13% ahead of its 200.00p float price.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
17 Feb 2022 22:13

TRADING UPDATES: Novacyt gets UK approval; Nostra spuds Cypress well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

Read more
17 Feb 2022 09:09

Oncimmune's EarlyCDT Lung test granted approval by Ministry of Health for Aragon

(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that its EarlyCDT Lung test had been granted approval by the Ministry of Health for Aragon in Spain and will now be adopted in the University Hospital Miguel Servet in Zaragoza.

Read more
15 Feb 2022 22:16

TRADING UPDATES: Burford, Frenkel Topping expect contrasting results

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
31 Dec 2021 11:20

Oncimmune reports fresh research from Cedars-Sinai Covid study

(Sharecast News) - Oncimmune announced the publication of a paper arising from the research collaboration with Cedars-Sinai Medical Center in Los Angeles on Friday, focusing on the sex-specific autoimmune reactivity to SARS-CoV-2 - the virus which causes Covid-19 - following mildly symptomatic infection.

Read more
31 Dec 2021 08:32

Oncimmune study suggests antibodies spike following Covid infection

Oncimmune study suggests antibodies spike following Covid infection

Read more
21 Dec 2021 14:25

Oncimmune shares up after multiple commercial contract wins

Oncimmune shares up after multiple commercial contract wins

Read more
21 Dec 2021 13:07

Oncimmune signs new commercial contracts

(Sharecast News) - Oncimmune Holdings announced on Tuesday that it has signed further commercial contracts within its 'ImmunoINSIGHTS' pharma services business.

Read more
19 Nov 2021 16:06

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
2 Nov 2021 15:55

TRADING UPDATES: Annual profit rises for UP Global Sourcing, Beximco

TRADING UPDATES: Annual profit rises for UP Global Sourcing, Beximco

Read more
2 Nov 2021 09:57

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

Read more
29 Oct 2021 15:57

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

Read more
26 Oct 2021 16:03

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Sep 2021 13:47

Oncimmune inks profiling contract with unnamed global pharma company

Oncimmune inks profiling contract with unnamed global pharma company

Read more
20 Sep 2021 11:24

Oncimmune inks deal with global pharma firm

(Sharecast News) - Immunodiagnostics company Oncimmune has signed an autoantibody profiling agreement with an unnamed global pharmaceutical company, it announced on Monday, to evaluate the autoantibody profiles of patient samples in various autoimmune diseases.

Read more
23 Aug 2021 15:12

Oncimmune upbeat on three-year lung cancer test study

(Sharecast News) - Immunodiagnostics group Oncimmune announced the pre-publication of the three-year follow-up data for the 'Early detection of Cancer of the Lung Scotland' (ECLS) trial on Monday, which showed that after three years, the number of late-stage cancers and deaths were lower in patients tested with the 'EarlyCDT Lung' blood test.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.